Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma
Table 2
Correlation between the fecal level of Gal-3 and parameters of disease severity and progression in patients with CRC and UC. Statistical significance was tested by Spearman correlation coefficient.